A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1997
12/09/1997	US5696108 Protein kinase C inhibitors
12/09/1997	US5695955 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/09/1997	US5695749 Oil-free edible bar comprising anticholesterol agent and starch, bran filler
12/09/1997	CA2127115C Methane diphosphonic acid derivative, its production process and its pharmaceutical applications
12/09/1997	CA2063598C Slimming pharmaceutical composition
12/04/1997	WO1997045425A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
12/04/1997	WO1997045417A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045135A1 Stable pharmaceutical composition of bdnf
12/04/1997	WO1997039749A3 Method for the prevention and treatment of cachexia and anorexia
12/04/1997	WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
12/04/1997	DE19622222A1 Use of sodium=proton exchange inhibitor
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2227811A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0810220A1 Arylacrylamide derivatives as 5HT1 agonists or antagonists
12/03/1997	EP0810207A1 Bis-ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/03/1997	EP0810206A1 Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
12/03/1997	EP0810205A1 Substituted 1-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/03/1997	EP0809692A1 Materials and methods relating to the regulation of polypeptide production in cells
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809623A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809512A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
12/03/1997	EP0809511A1 Inhibition of angiogenesis using interleukin-12
12/03/1997	EP0809507A1 Novel highly potent agonists of growth hormone releasing hormone
12/03/1997	EP0809502A1 Method of lessening the risk of non-vertebral bone fractures
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809494A1 The use of heterocyclic compounds
12/03/1997	CN1036588C Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms
12/02/1997	US5693675 Alkylated amine polymers
12/02/1997	US5693672 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
12/02/1997	US5693665 Alkylated (hetero) cyclic compounds
12/02/1997	US5693664 Use of R-(+)-α-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the form of the free acid or salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
12/02/1997	US5693657 Useful for treating hypercholesterolemia or atherosclerosis
12/02/1997	US5693651 Quinoline derivatives
12/02/1997	US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/02/1997	US5693609 Antidiabetic agents; extended duration of action
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
12/02/1997	US5693479 Obtaining trophoblast sample from conceptus prior to uterine implantation of the conceptus, administering transforming growth factor to sample, evaluating production by the sample of trophoblast fibronectin
11/1997
11/29/1997	CA2177553A1 Thiazolidinedione derivatives or salts thereof and pharmaceutical compositions containing the same
11/28/1997	CA2206198A1 Bis-ortho-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/27/1997	WO1997044357A1 Synthetic glucagon binding proteins
11/27/1997	WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	WO1997044324A1 Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
11/27/1997	WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997	WO1997044029A1 Methods of increasing nitric oxide synthesis
11/27/1997	CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	CA2255792A1 Methods of increasing nitric oxide synthesis
11/27/1997	CA2255541A1 Synthetic glucagon binding proteins
11/26/1997	EP0808833A2 Vitamin D3 analogs
11/26/1997	EP0808832A2 Fluorinated vitamin D3 analogs
11/26/1997	EP0808831A2 Fluorinated vitamin D3 analogs
11/26/1997	EP0808365A1 Human interleukin-1 receptor accessory protein
11/26/1997	EP0808364A1 Human pancreatic cell lines: developments and uses
11/26/1997	EP0808314A1 New forms of paroxetin hydrochloride
11/26/1997	EP0808164A1 Method for treatment of obesity using prolactin modulators and diet
11/26/1997	EP0808163A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
11/26/1997	EP0808111A1 A LOW PHOSPHORUS ANIMAL FEED CONTAINING 1$g(a)-HYDROXYLATED VITAMIN D COMPOUNDS
11/26/1997	CN1166174A Sterol compsns. from pulping soap
11/26/1997	CN1165651A Use of (E)-1£4'-(2-alkylaminoethioxy) phenyl\|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
11/25/1997	US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes
11/25/1997	US5691375 Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
11/25/1997	US5691373 Nonpeptide endothelin antagonists I
11/25/1997	US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds
11/25/1997	US5691349 Quinclidine derivatives as squalene synthase inhibitors
11/25/1997	US5691336 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
11/25/1997	US5691306 Protein secretion
11/20/1997	WO1997043273A1 Substituted 1, 3-benzodioxoles
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997043235A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/20/1997	WO1997042979A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	WO1997042956A1 Didhydropyrimidines and uses thereof
11/20/1997	WO1997042941A2 Buccal delivery system
11/20/1997	WO1997042916A1 Method suitable for influencing the ingestion of food by humans via the mouth cavity
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	WO1997030677A3 Pentafluorobenzenesulfonamides and analogs
11/20/1997	CA2255589A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/20/1997	CA2254126A1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	CA2254120A1 Substituted 1, 3-benzodioxoles
11/20/1997	CA2253862A1 Dihydropyrimidines and uses thereof
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807627A2 Anilide compounds as ACAT inhibitors
11/19/1997	EP0807624A2 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
11/19/1997	EP0807429A1 Cosmetic composition with retinol unsaturated fatty acid esters
11/19/1997	EP0807185A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
11/19/1997	EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors
11/19/1997	EP0806961A1 Anti-obesity proteins
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997	EP0598093B1 Quinuclidine derivatives as squalene synthetase inhibitors
11/19/1997	CN1165477A Delivery of solid drug compositions
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes
11/18/1997	US5688990 Forming chemical intermediates for azetidinone compounds that inhibit cholesterol biosynthesis for prevention of atherosclerosis
11/18/1997	US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997	US5688938 Calcium receptor-active molecules
11/18/1997	US5688818 Enzyme inhibitors

1 ... 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 ... 1298